ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,851, issued on Aug. 25, was assigned to Stellenbosch University (Stellenbosch, South Africa) and Jawaharlal Nehru University (New Delhi).
"4'-substituted analogues of fisetin and their use in the treatment of cancer" was invented by Catherine Hart Kaschula (Stellenbosch, Canada), Rana Pratap Singh (New Delhi), Arpit Dheeraj (New Delhi) and Akash Sabarwal (New Delhi).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to compounds that are 4'-substituted analogues of the flavonol Fisetin. In particular, the invention relates to such compounds wherein the 4' position on the B-ring is substituted with a ring deactivating group which ha...